Dolphin Medical Services (BSE 526504)₹7.11+4.87%Healthcare Service Provider
In the Mar 2026 quarter (standalone), Dolphin Medical Services reported sales of ₹0.18 Cr, up 38.5% from Mar 2025, and net profit of ₹0.02 Cr. For the year to Mar 2026, sales were ₹0.74 Cr and net profit ₹0.05 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.14 | 0.17 | 0.19 | 0.13 | 0.13 | 0.24 | 0.23 | 0.13 | 0.16 | 0.17 | 0.20 | 0.18 |
| Expenses | 0.12 | 0.16 | 0.19 | 0.26 | 0.12 | 0.22 | 0.22 | 0.18 | 0.13 | 0.15 | 0.17 | 0.16 |
| Operating Profit | 0.03 | 0.02 | 0.00 | −0.14 | 0.02 | 0.03 | 0.02 | −0.06 | 0.04 | 0.03 | 0.04 | 0.03 |
| OPM % | 13.3% | 5.6% | 0.0% | −92.9% | 7.1% | 8.0% | 4.2% | −35.7% | 17.6% | 11.1% | 14.3% | 10.5% |
| Other Income | 0.02 | 0.00 | 0.00 | 0.02 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.04 | 0.02 | 0.04 | 0.04 | 0.03 |
| Profit before tax | 0.03 | 0.02 | 0.00 | −0.14 | 0.02 | 0.03 | 0.02 | −0.08 | 0.04 | 0.00 | 0.02 | 0.02 |
| Tax % | 0.0% | 0.0% | — | 7.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | 0.0% | 0.0% |
| Net Profit | 0.02 | 0.02 | 0.00 | −0.14 | 0.02 | 0.03 | 0.02 | −0.08 | 0.04 | 0.02 | 0.03 | 0.02 |
| EPS (Rs) | 0.02 | 0.00 | 0.00 | −0.08 | 0.00 | 0.00 | 0.00 | −0.04 | 0.01 | 0.00 | 0.00 | 0.00 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.56 | 0.34 | 0.14 | 0.05 | 0.17 | 0.46 | 0.51 | 0.60 | 0.67 | 0.77 | 0.74 | 0.71 |
| Expenses | 0.38 | 0.32 | 0.22 | 0.19 | 0.51 | 6.23 | 0.65 | 0.68 | 0.75 | 0.77 | 0.62 | 0.61 |
| Operating Profit | 0.19 | 0.03 | −0.09 | −0.15 | −0.35 | −5.78 | −0.15 | −0.09 | −0.09 | 0.00 | 0.13 | 0.14 |
| OPM % | 31.6% | 5.7% | −53.3% | −233.4% | −188.9% | −1,227.7% | −27.0% | −13.1% | −11.8% | 0.0% | 16.0% | 19.7% |
| Other Income | 0.14 | 0.01 | 0.08 | −0.64 | 0.04 | 5.54 | 0.05 | 0.03 | 0.05 | 0.03 | 0.05 | 0.02 |
| Interest | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.35 | 0.34 | 0.34 | 0.25 | 0.07 | 0.07 | 0.07 | 0.07 | 0.06 | 0.07 | 0.10 | 0.13 |
| Profit before tax | −0.08 | −0.31 | −0.34 | −1.03 | −0.37 | −0.30 | −0.18 | −0.12 | −0.11 | −0.04 | 0.07 | 0.08 |
| Tax % | −28.6% | −10.1% | −12.2% | −2.0% | 5.5% | 6.9% | 5.9% | 9.0% | 10.0% | 0.0% | 33.3% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | −0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | −0.06 | −0.28 | −0.31 | −1.02 | −0.40 | −0.32 | −0.20 | −0.13 | −0.11 | −0.04 | 0.05 | 0.11 |
| EPS (Rs) | −0.02 | −0.19 | −0.19 | −0.66 | −0.25 | −0.20 | −0.12 | −0.09 | −0.06 | −0.01 | 0.02 | 0.01 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15.09 | 15.08 | 15.09 | 15.09 | 15.08 | 15.08 | 15.10 | 15.09 | 15.11 | 15.10 | 15.11 | 15.08 |
| Reserves | −2.31 | −2.35 | −2.62 | −2.92 | −3.92 | −4.31 | −4.61 | −4.81 | −4.93 | −5.03 | −5.07 | −5.03 |
| Borrowings | 8.05 | 8.16 | 8.22 | 8.22 | 6.22 | 6.37 | 0.62 | 0.69 | 0.75 | 0.81 | 0.88 | 0.88 |
| Other Liabilities | 0.74 | 0.67 | 0.64 | 0.62 | 0.57 | 0.70 | 1.24 | 1.27 | 1.24 | 1.28 | 1.16 | 1.49 |
| Total Liabilities | 21.57 | 21.56 | 21.33 | 21.01 | 17.95 | 17.84 | 12.35 | 12.24 | 12.17 | 12.16 | 12.08 | 12.42 |
| Fixed Assets | 14.45 | 10.32 | 10.00 | 9.67 | 6.76 | 6.71 | 2.99 | 2.93 | 2.86 | 2.82 | 2.75 | 6.89 |
| CWIP | 2.15 | 5.94 | 5.94 | 5.94 | 5.92 | 5.92 | 4.10 | 4.10 | 4.10 | 4.10 | 4.08 | 0.32 |
| Investments | 0.53 | 0.53 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 |
| Other Assets | 4.44 | 4.77 | 4.97 | 4.98 | 4.85 | 4.79 | 4.84 | 4.79 | 4.79 | 4.82 | 4.83 | 4.79 |
| Inventories | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.02 |
| Cash & equivalents | 0.02 | 0.02 | 0.02 | 0.02 | 0.00 | 0.02 | 0.05 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 |
| Total Assets | 21.57 | 21.56 | 21.33 | 21.01 | 17.95 | 17.84 | 12.35 | 12.24 | 12.17 | 12.16 | 12.08 | 12.42 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 0.04 | −0.11 | −0.06 | 0.01 | −0.12 | 0.26 | −0.09 | −0.06 | −0.04 | −0.05 | 0.13 |
| Cash from investing activity | 0.00 | 0.00 | 0.04 | 1.98 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −0.46 |
| Cash from financing activity | −0.06 | 0.12 | 0.06 | −2.00 | 0.16 | −0.26 | 0.08 | 0.08 | 0.06 | 0.07 | 0.32 |
| Net cash flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.04 | −0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capex | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.46 |
| Free cash flow | 0.04 | −0.10 | −0.06 | 1.98 | −0.13 | 0.26 | −0.09 | −0.06 | −0.04 | −0.05 | −0.30 |
| CFO / OP % | −167.0% | −56.0% | −200.0% | −14.0% | 38.0% | −5.0% | 71.0% | 88.0% | 62.0% | — | 117.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory days | 36 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 32 | 29 | 36 |
| Days payable | 72 | 0 | — | — | — | — | — | — | — | 0 | 0 | 0 |
| Cash conversion cycle | −36 | 22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34 | 31 | 38 |
| Working capital days | 1,449 | 1,171 | 2,106 | 4,890 | 11,618 | 3,629 | 985 | 897 | 771 | 686 | 645 | 515 |
| ROCE % | −2.6% | −0.1% | −1.0% | −1.6% | −1.7% | −2.0% | −2.0% | −1.5% | −0.9% | −0.8% | −0.2% | 0.6% |
For the Mar 2026 quarter, Dolphin Medical Services reported sales of ₹0.18 Cr, up 38.5% year on year and net profit of ₹0.02 Cr. The operating margin was 10.5%.
Dolphin Medical Services' sales for the year to Mar 2026 were ₹0.74 Cr; over the last twelve months they were ₹0.71 Cr.
Net profit for the year to Mar 2026 was ₹0.05 Cr, and ₹0.11 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.01.
Dolphin Medical Services reported borrowings of ₹0.88 Cr at Mar 2026, against cash and equivalents of ₹0.03 Cr.
Cash from operations was ₹0.13 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹0.30 Cr.